MIME-Version: 1.0
Received: by 10.31.14.68 with HTTP; Wed, 6 Jan 2016 23:50:06 -0800 (PST)
In-Reply-To: <FD776FCE5BFEC045840FAB11F4BAF354B6377E6E@PRNEX2010.nucleus.local>
References: <FD776FCE5BFEC045840FAB11F4BAF354B6377E6E@PRNEX2010.nucleus.local>
Date: Thu, 7 Jan 2016 18:50:06 +1100
Delivered-To: sometime5858@gmail.com
Message-ID: <CAGiHyzfsFxYZ_beqHNehGss8yR5sKwXkwPDbFzmVeRN7LKu_Aw@mail.gmail.com>
Subject: Re: PTG- short clinical trial $1,800
From: Albert Wang <sometime5858@gmail.com>
To: Louise Gonzales <L.Gonzales@nucleusnetwork.com.au>
Content-Type: multipart/related; boundary=94eb2c07d8e417d0f50528b9b821
X-TUID: yOAjKiQjUYDX

--94eb2c07d8e417d0f50528b9b821
Content-Type: multipart/alternative; boundary=94eb2c07d8e417d0f30528b9b820

--94eb2c07d8e417d0f30528b9b820
Content-Type: text/plain; charset=UTF-8
Content-Transfer-Encoding: quoted-printable

Hi Officer Louise,

I would like to participate in this study and am able to do all the times
on the schedule. You could contact me for booking a screening check up if
you still need more participants.

No.: 0404 626 535
Or this email address.

Regards,
Aohan

On Thu, Jan 7, 2016 at 3:10 PM, Louise Gonzales <
L.Gonzales@nucleusnetwork.com.au> wrote:

> Hello,
>
>
>
> Thank you for your ongoing interest in our clinical studies.
>
>
>
> Listed below is a brief outline of a new study and two study date
> schedules.
>
>
>
> If you are interested in the study below, please call us on *1800 243 733=
*
> (we call on a *private number)*or respond to this email as we need to
> book you for a screening visit (medical check up) either on
>
> =C2=B7         *Monday 11 January or *
>
> =C2=B7         *Tuesday 12 January*.
>
>
>
> *PTG-100-01:* This study is investigating a new drug that has been
> developed as a treatment for ulcerative colitis (UC) which is an
> inflammatory bowel disease (IBD) characterised by bloody diarrhoea,
> abdominal cramps and fatigue. Current treatments for this complex disease
> may be only mildly effective, have unacceptable side effects, or cannot b=
e
> used long-term as they suppress the immune system and may increase the ri=
sk
> of serious infection or cancer.
>
> One of the major causes of gastric damage in UC is inflammation in the gu=
t
> that may be related to the accumulation of a specific white blood cell ty=
pe
> called leukocytes. A key protein is found on the surface of leukocytes an=
d
> helps the leukocytes move to the gut and cause inflammation. PTG-100 can
> specifically block the protein and thereby has the potential to decrease
> the gut inflammation that causes the symptoms of UC. In fact, another
> inhibitor called vedolizumab (marketed as Entyvio=C2=AE) has recently bee=
n
> approved for use in Australia for treatment of patients with UC.
>
> Vedolizumab is generally safe and well-tolerated in patients with UC.
> However vedolizumab is an intravenous (into the vein) infusion meaning it
> needs to be administered by a health professional. *PTG-100* which we are
> investigating in this study, can be administered as a drinkable liquid an=
d
> thus it is hoped will be a better treatment option for UC sufferers.
>
>
>
> *Please click here for the Participant Information and Consent form for
> more information
> <http://clinicalstudies.com.au/wp-content/uploads/2015/12/PTG-100-01.pdf>=
 *
>
>
>
> *Volunteers required: *
>
> =C2=B7         Healthy men
>
> =C2=B7         Aged 19 =E2=80=93 55 years
>
> =C2=B7         BMI 18 =E2=80=93 30 inclusive
>
> =C2=B7         Non smokers for at least *3 months* (there will be a nicot=
ine
> test)
>
> =C2=B7         Not taking any medications
>
> =C2=B7         No dietary restrictions. You need to be able to eat a brea=
kfast
> with bacon, full cream milk, toast, butter and hash browns.
>
>
>
> *Study Duration*
>
> =C2=B7          6 days & nights as an inpatient *(separated into 2 period=
s)*
>
> =C2=B7          1 outpatient visit
>
>
>
> *Our Location*      Centre for Clinical Studies (AMREP Precinct Alfred
> Hospital) AMREP access map
> <http://clinicalstudies.com.au/wp-content/uploads/2014/02/AMREP-CCS-Acces=
s-MAP.pdf>
>
>                                 Level 5, 89 Commercial Road,
>
>                                 Melbourne, 3004.
>
>                               Click here
> <https://maps.google.com.au/maps?q=3D89+commercial+road+melbourne+3004&ie=
=3DUTF-8&hq=3D&hnear=3D0x6ad66822902afed9:0xca1cf794638a5956,85-89+Commerci=
al+Rd,+Melbourne+VIC+3004&gl=3Dau&ei=3DrwD8UqTNL4GRkwX88YH4Aw&ved=3D0CCYQ8g=
EwAA>
> for the *Google map*.
>
>
>
> *Reimbursement*: *$1800*
>
>
>
> *Study Schedule:*
>
> *You need to be able to do ALL DATES in the table below*
>
> *Study Day*
>
>
>
> *Date*
>
> *Time*
>
> *Comments*
>
> *On Study *
>
> Day -1
>
> Thursday, 14 January 2016
>
> 14:00
>
> Check-in
>
>
>
> Day 3
>
> Sunday, 17 January 2016
>
> 10.00am
>
> check out
>
> *On Study *
>
> Day -1
>
> Thursday, 21 January 2016
>
> 14:00
>
> Check-in
>
>
>
> Day 3
>
> Sunday, 24 January 2016
>
> 10.00am
>
> check out
>
> *Final Visit*
>
> Day 7
>
> Thursday, 28 January 2016
>
> ~2hrs
>
> Outpatient
>
>
>
> To view our Participant Information Brochure please click here
> <http://clinicalstudies.com.au/wp-content/uploads/2014/02/CCS-Volunteer-B=
rochure.pdf>
> and read more about our organisation and about clinical trials generally.
>
>
>
> Please also visit our website at www.clinicalstudies.com.au
>
>
>
> *If you do not wish to receive any further emails from us then please
> reply to this email with the word =E2=80=98unsubscribe=E2=80=99 in the su=
bject box.*
>
>
>
> Thanking you again for your interest.
>
>
>
>
>
> Warm Regards,
>
> Louise
>
>
>
> *Louise Gonzales**|* *Senior Recruitment Officer* *|* *Centre for
> Clinical Studies* *|*
> *Office|* Level 5 Burnet Institute, AMREP Precinct | 89 Commercial Road
> Melbourne Victoria 3004, Australia *|*
> *T*  61 3 9076 9019 | *F* 61 3 9076 8940 |* E *
> *l.gonzales@nucleusnetwork.com.au* <l.gonzales@nucleusnetwork.com.au> |
> *W*  *www.clinicalstudies.com.au* <http://www.clinicalstudies.com.au> |
>
> *1800 243 733*
>
> <http://www.facebook.com/pages/Centre-for-Clinical-Studies/19937151341784=
2>
>  You can now follow us on Facebook
>
>
>
> *Nucleus Network, Australia's Clinical Research Centre, operates in
> association with Centre for Clinical Studies, *
>
> *Clinical Trials Consulting and its network partners*
>
> P  *Please consider the environment before printing this e-mail*
>
>
>
>
>
>
>
>
>
> ______________________________________________________________________
> This email has been scanned by the Symantec Email Security.cloud service.
> For more information please visit http://www.symanteccloud.com
> ______________________________________________________________________
>

--94eb2c07d8e417d0f30528b9b820
Content-Type: text/html; charset=UTF-8
Content-Transfer-Encoding: quoted-printable

<div dir=3D"ltr"><div><div><div><div><div>Hi Officer Louise,<br><br></div>I=
 would like to participate in this study and am able to do all the times on=
 the schedule. You could contact me for booking a screening check up if you=
 still need more participants. <br><br></div>No.: 0404 626 535<br></div>Or =
this email address. <br><br></div>Regards,<br></div>Aohan<br></div><div cla=
ss=3D"gmail_extra"><br><div class=3D"gmail_quote">On Thu, Jan 7, 2016 at 3:=
10 PM, Louise Gonzales <span dir=3D"ltr">&lt;<a href=3D"mailto:L.Gonzales@n=
ucleusnetwork.com.au" target=3D"_blank">L.Gonzales@nucleusnetwork.com.au</a=
>&gt;</span> wrote:<br><blockquote class=3D"gmail_quote" style=3D"margin:0 =
0 0 .8ex;border-left:1px #ccc solid;padding-left:1ex">





<div link=3D"blue" vlink=3D"purple" lang=3D"EN-AU">
<div>
<p class=3D"MsoNormal"><span lang=3D"EN-US">Hello,<u></u><u></u></span></p>
<p class=3D"MsoNormal"><span lang=3D"EN-US"><u></u>=C2=A0<u></u></span></p>
<p class=3D"MsoNormal"><span lang=3D"EN-US">Thank you for your ongoing inte=
rest in our<span style=3D"color:black"> clinical studies.
<u></u><u></u></span></span></p>
<p class=3D"MsoNormal"><span style=3D"color:#1f497d" lang=3D"EN-US"><u></u>=
=C2=A0<u></u></span></p>
<p><span style=3D"font-size:11.0pt;font-family:&quot;Calibri&quot;,&quot;sa=
ns-serif&quot;">Listed below is a brief outline of a new study and two stud=
y date schedules.
<u></u><u></u></span></p>
<p><span style=3D"font-size:11.0pt;font-family:&quot;Calibri&quot;,&quot;sa=
ns-serif&quot;;color:#1f497d"><u></u>=C2=A0<u></u></span></p>
<p style=3D"text-align:center" align=3D"center"><span style=3D"font-size:11=
.0pt;font-family:&quot;Calibri&quot;,&quot;sans-serif&quot;;color:#db1803">=
If you are interested in the study below, please call us on
</span><b><span style=3D"font-size:14.0pt;font-family:&quot;Calibri&quot;,&=
quot;sans-serif&quot;;color:#db1803">1800 243 733</span></b><span style=3D"=
font-size:11.0pt;font-family:&quot;Calibri&quot;,&quot;sans-serif&quot;;col=
or:#db1803"> (we call on a
<u>private number)</u>or respond to this email as we need to book you for a=
 screening visit (medical check up) either on<u></u><u></u></span></p>
<p style=3D"margin-left:36.0pt;text-align:center" align=3D"center">
<u></u><span style=3D"font-size:11.0pt;font-family:Symbol;color:#db1803"><s=
pan>=C2=B7<span style=3D"font:7.0pt &quot;Times New Roman&quot;">=C2=A0=C2=
=A0=C2=A0=C2=A0=C2=A0=C2=A0=C2=A0=C2=A0
</span></span></span><u></u><b><span style=3D"font-size:11.0pt;font-family:=
&quot;Calibri&quot;,&quot;sans-serif&quot;;color:#db1803">Monday 11 January=
 or
</span></b><span style=3D"font-size:11.0pt;font-family:&quot;Calibri&quot;,=
&quot;sans-serif&quot;;color:#db1803"><u></u><u></u></span></p>
<p style=3D"margin-left:36.0pt;text-align:center" align=3D"center">
<u></u><span style=3D"font-size:11.0pt;font-family:Symbol;color:#db1803"><s=
pan>=C2=B7<span style=3D"font:7.0pt &quot;Times New Roman&quot;">=C2=A0=C2=
=A0=C2=A0=C2=A0=C2=A0=C2=A0=C2=A0=C2=A0
</span></span></span><u></u><b><span style=3D"font-size:11.0pt;font-family:=
&quot;Calibri&quot;,&quot;sans-serif&quot;;color:#db1803">Tuesday 12 Januar=
y</span></b><span style=3D"font-size:11.0pt;font-family:&quot;Calibri&quot;=
,&quot;sans-serif&quot;;color:#db1803">.<u></u><u></u></span></p>
<p><span style=3D"font-size:11.0pt;font-family:&quot;Calibri&quot;,&quot;sa=
ns-serif&quot;;color:#1f497d">=C2=A0=C2=A0=C2=A0=C2=A0=C2=A0=C2=A0=C2=A0=C2=
=A0=C2=A0=C2=A0=C2=A0=C2=A0=C2=A0=C2=A0=C2=A0
<u></u><u></u></span></p>
<p><b><span style=3D"font-size:11.0pt;font-family:&quot;Calibri&quot;,&quot=
;sans-serif&quot;;color:black">PTG-100-01:</span></b><span style=3D"font-si=
ze:11.0pt;font-family:&quot;Calibri&quot;,&quot;sans-serif&quot;">=C2=A0Thi=
s study is investigating a</span><span style=3D"font-size:11.0pt;font-famil=
y:&quot;Calibri&quot;,&quot;sans-serif&quot;;color:windowtext">
 new</span><span style=3D"font-size:11.0pt;font-family:&quot;Calibri&quot;,=
&quot;sans-serif&quot;;color:#1f497d">
</span><span style=3D"font-size:11.0pt;font-family:&quot;Calibri&quot;,&quo=
t;sans-serif&quot;">drug that has been developed as a treatment for ulcerat=
ive colitis (UC) which is an inflammatory bowel disease (IBD) characterised=
 by bloody diarrhoea, abdominal cramps and fatigue. Current
 treatments for this complex disease may be only mildly effective, have una=
cceptable side effects, or cannot be used long-term as they suppress the im=
mune system and may increase the risk of serious infection or cancer.
<u></u><u></u></span></p>
<p><span style=3D"font-size:11.0pt;font-family:&quot;Calibri&quot;,&quot;sa=
ns-serif&quot;">One of the major causes of gastric damage in UC is inflamma=
tion in the gut that may be related to the accumulation of a specific white=
 blood cell type called leukocytes. A
 key protein is found on the surface of leukocytes and helps the leukocytes=
 move to the gut and cause inflammation. PTG-100 can specifically block the=
 protein and thereby has the potential to decrease the gut inflammation tha=
t causes the symptoms of UC. In
 fact, another inhibitor called vedolizumab (marketed as Entyvio=C2=AE) has=
 recently been approved for use in Australia for treatment of patients with=
 UC.
<u></u><u></u></span></p>
<p><span style=3D"font-size:11.0pt;font-family:&quot;Calibri&quot;,&quot;sa=
ns-serif&quot;">Vedolizumab is generally safe and well-tolerated in patient=
s with UC. However vedolizumab is an intravenous (into the vein) infusion m=
eaning it needs to be administered by
 a health professional. </span><b><span style=3D"font-size:11.0pt;font-fami=
ly:&quot;Calibri&quot;,&quot;sans-serif&quot;;color:black">PTG-100</span></=
b><span style=3D"font-size:11.0pt;font-family:&quot;Calibri&quot;,&quot;san=
s-serif&quot;"> which we are investigating in this study, can be administer=
ed
 as a drinkable liquid and thus it is hoped will be a better treatment opti=
on for UC sufferers.</span><span style=3D"font-size:11.0pt;font-family:&quo=
t;Calibri&quot;,&quot;sans-serif&quot;;color:#1f497d"><u></u><u></u></span>=
</p>
<p><span style=3D"font-size:11.0pt;font-family:&quot;Calibri&quot;,&quot;sa=
ns-serif&quot;;color:#1f497d"><u></u>=C2=A0<u></u></span></p>
<p><b><u><span style=3D"font-size:11.0pt;font-family:&quot;Calibri&quot;,&q=
uot;sans-serif&quot;;color:red"><a href=3D"http://clinicalstudies.com.au/wp=
-content/uploads/2015/12/PTG-100-01.pdf" target=3D"_blank">Please click her=
e for the Participant Information and Consent form for more
 information</a> <u></u><u></u></span></u></b></p>
<p><span style=3D"font-size:11.0pt;font-family:&quot;Calibri&quot;,&quot;sa=
ns-serif&quot;;color:#1f497d"><u></u>=C2=A0<u></u></span></p>
<p class=3D"MsoNormal"><b>Volunteers required: <u></u><u></u></b></p>
<p><u></u><span style=3D"font-family:Symbol"><span>=C2=B7<span style=3D"fon=
t:7.0pt &quot;Times New Roman&quot;">=C2=A0=C2=A0=C2=A0=C2=A0=C2=A0=C2=A0=
=C2=A0=C2=A0
</span></span></span><u></u>Healthy men<u></u><u></u></p>
<p><u></u><span style=3D"font-family:Symbol"><span>=C2=B7<span style=3D"fon=
t:7.0pt &quot;Times New Roman&quot;">=C2=A0=C2=A0=C2=A0=C2=A0=C2=A0=C2=A0=
=C2=A0=C2=A0
</span></span></span><u></u>Aged 19 =E2=80=93 55 years <u></u><u></u></p>
<p><u></u><span style=3D"font-family:Symbol"><span>=C2=B7<span style=3D"fon=
t:7.0pt &quot;Times New Roman&quot;">=C2=A0=C2=A0=C2=A0=C2=A0=C2=A0=C2=A0=
=C2=A0=C2=A0
</span></span></span><u></u>BMI 18 =E2=80=93 30 inclusive<u></u><u></u></p>
<p><u></u><span style=3D"font-family:Symbol"><span>=C2=B7<span style=3D"fon=
t:7.0pt &quot;Times New Roman&quot;">=C2=A0=C2=A0=C2=A0=C2=A0=C2=A0=C2=A0=
=C2=A0=C2=A0
</span></span></span><u></u>Non smokers for at least <u>3 months</u><span s=
tyle=3D"color:#1f497d">
</span><span style=3D"color:black">(there will be a nicotine test)</span><u=
></u><u></u></p>
<p><u></u><span style=3D"font-family:Symbol"><span>=C2=B7<span style=3D"fon=
t:7.0pt &quot;Times New Roman&quot;">=C2=A0=C2=A0=C2=A0=C2=A0=C2=A0=C2=A0=
=C2=A0=C2=A0
</span></span></span><u></u>Not taking any medications <u></u><u></u></p>
<p><u></u><span style=3D"font-family:Symbol"><span>=C2=B7<span style=3D"fon=
t:7.0pt &quot;Times New Roman&quot;">=C2=A0=C2=A0=C2=A0=C2=A0=C2=A0=C2=A0=
=C2=A0=C2=A0
</span></span></span><u></u>No dietary restrictions<span style=3D"color:#1f=
497d">.
</span><span style=3D"color:black">You need to be able to eat a breakfast w=
ith bacon, full cream milk, toast, butter and hash browns.</span><span styl=
e=3D"color:#1f497d">
</span><u></u><u></u></p>
<p class=3D"MsoNormal"><span style=3D"color:#1f497d"><u></u>=C2=A0<u></u></=
span></p>
<p><b><span style=3D"font-size:11.0pt;font-family:&quot;Calibri&quot;,&quot=
;sans-serif&quot;">Study Duration<u></u><u></u></span></b></p>
<p style=3D"margin-left:36.0pt">
<u></u><span style=3D"font-size:11.0pt;font-family:Symbol"><span>=C2=B7<spa=
n style=3D"font:7.0pt &quot;Times New Roman&quot;">=C2=A0=C2=A0=C2=A0=C2=A0=
=C2=A0=C2=A0=C2=A0=C2=A0
</span></span></span><u></u><span style=3D"font-size:11.0pt;font-family:&qu=
ot;Calibri&quot;,&quot;sans-serif&quot;">=C2=A06 days &amp; nights as an
<span style=3D"color:black">inpatient <i>(separated into 2 periods)</i></sp=
an><u></u><u></u></span></p>
<p style=3D"margin-left:36.0pt">
<u></u><span style=3D"font-size:11.0pt;font-family:Symbol"><span>=C2=B7<spa=
n style=3D"font:7.0pt &quot;Times New Roman&quot;">=C2=A0=C2=A0=C2=A0=C2=A0=
=C2=A0=C2=A0=C2=A0=C2=A0
</span></span></span><u></u><span style=3D"font-size:11.0pt;font-family:&qu=
ot;Calibri&quot;,&quot;sans-serif&quot;">=C2=A01 outpatient visit<u></u><u>=
</u></span></p>
<p><span style=3D"font-size:11.0pt;font-family:&quot;Calibri&quot;,&quot;sa=
ns-serif&quot;"><u></u>=C2=A0<u></u></span></p>
<p class=3D"MsoNormal"><b>Our Location</b>=C2=A0=C2=A0=C2=A0=C2=A0=C2=A0 Ce=
ntre for Clinical Studies <span lang=3D"EN-US">
(AMREP Precinct Alfred Hospital)<span style=3D"color:#0033cc"> </span></spa=
n><span style=3D"color:blue"><a href=3D"http://clinicalstudies.com.au/wp-co=
ntent/uploads/2014/02/AMREP-CCS-Access-MAP.pdf" target=3D"_blank">AMREP acc=
ess map</a></span><span style=3D"color:#1f497d"><u></u><u></u></span></p>
<p class=3D"MsoNormal"><span lang=3D"EN-US">=C2=A0=C2=A0=C2=A0=C2=A0=C2=A0=
=C2=A0=C2=A0=C2=A0=C2=A0=C2=A0=C2=A0=C2=A0=C2=A0=C2=A0=C2=A0 =C2=A0=C2=A0=
=C2=A0=C2=A0=C2=A0=C2=A0=C2=A0=C2=A0=C2=A0=C2=A0=C2=A0=C2=A0=C2=A0=C2=A0=C2=
=A0 Level 5, 89 Commercial Road,
<u></u><u></u></span></p>
<p class=3D"MsoNormal"><span lang=3D"EN-US">=C2=A0=C2=A0=C2=A0=C2=A0=C2=A0=
=C2=A0=C2=A0=C2=A0=C2=A0=C2=A0=C2=A0=C2=A0=C2=A0=C2=A0=C2=A0 =C2=A0=C2=A0=
=C2=A0=C2=A0=C2=A0=C2=A0=C2=A0=C2=A0=C2=A0=C2=A0=C2=A0=C2=A0=C2=A0=C2=A0=C2=
=A0 Melbourne, 3004</span><span style=3D"color:blue">.</span><u></u><u></u>=
</p>
<p class=3D"MsoNormal">=C2=A0=C2=A0=C2=A0=C2=A0=C2=A0=C2=A0=C2=A0=C2=A0=C2=
=A0=C2=A0=C2=A0 =C2=A0=C2=A0=C2=A0=C2=A0=C2=A0=C2=A0=C2=A0=C2=A0=C2=A0=C2=
=A0=C2=A0 <span style=3D"color:#1f497d">=C2=A0=C2=A0=C2=A0=C2=A0=C2=A0 </sp=
an>
Click <a href=3D"https://maps.google.com.au/maps?q=3D89+commercial+road+mel=
bourne+3004&amp;ie=3DUTF-8&amp;hq=3D&amp;hnear=3D0x6ad66822902afed9:0xca1cf=
794638a5956,85-89+Commercial+Rd,+Melbourne+VIC+3004&amp;gl=3Dau&amp;ei=3Drw=
D8UqTNL4GRkwX88YH4Aw&amp;ved=3D0CCYQ8gEwAA" target=3D"_blank">
here</a> for the <b><span style=3D"color:#3333ff">Google map</span></b>.<u>=
</u><u></u></p>
<p class=3D"MsoNormal"><b><u></u>=C2=A0<u></u></b></p>
<p class=3D"MsoNormal"><b>Reimbursement</b>: <b><span style=3D"font-size:12=
.0pt;color:#00b050">$1800</span></b><b><span style=3D"font-size:12.0pt;colo=
r:#1f497d"><u></u><u></u></span></b></p>
<p class=3D"MsoNormal"><b><span style=3D"color:#1f497d"><u></u>=C2=A0<u></u=
></span></b></p>
<p class=3D"MsoNormal"><b>Study Schedule:<span style=3D"color:#1f497d"><u><=
/u><u></u></span></b></p>
<p class=3D"MsoNormal"><b><span style=3D"color:red">You need to be able to =
do ALL DATES in the table below<u></u><u></u></span></b></p>
<table style=3D"border-collapse:collapse" border=3D"0" cellpadding=3D"0" ce=
llspacing=3D"0">
<tbody>
<tr style=3D"height:14.3pt">
<td style=3D"width:63.6pt;border:solid black 1.0pt;border-right:none;backgr=
ound:#dbe5f1;padding:0cm 1.5pt 0cm 1.5pt;height:14.3pt" valign=3D"top" widt=
h=3D"85">
<p class=3D"MsoNormal" style=3D"text-align:center;text-autospace:none" alig=
n=3D"center">
<b><span style=3D"color:black">Study Day<u></u><u></u></span></b></p>
</td>
<td style=3D"width:87.1pt;border:solid black 1.0pt;border-left:none;backgro=
und:#dbe5f1;padding:0cm 1.5pt 0cm 1.5pt;height:14.3pt" valign=3D"top" width=
=3D"116">
<p class=3D"MsoNormal" style=3D"text-align:center;text-autospace:none" alig=
n=3D"center">
<b><span style=3D"color:black"><u></u>=C2=A0<u></u></span></b></p>
</td>
<td style=3D"width:151.5pt;border:solid black 1.0pt;border-left:none;backgr=
ound:#dbe5f1;padding:0cm 1.5pt 0cm 1.5pt;height:14.3pt" valign=3D"top" widt=
h=3D"202">
<p class=3D"MsoNormal" style=3D"text-align:center;text-autospace:none" alig=
n=3D"center">
<b><span style=3D"color:black">Date<u></u><u></u></span></b></p>
</td>
<td style=3D"width:63.75pt;border:solid black 1.0pt;border-left:none;backgr=
ound:#dbe5f1;padding:0cm 1.5pt 0cm 1.5pt;height:14.3pt" valign=3D"top" widt=
h=3D"85">
<p class=3D"MsoNormal" style=3D"text-align:center;text-autospace:none" alig=
n=3D"center">
<b><span style=3D"color:black">Time<u></u><u></u></span></b></p>
</td>
<td style=3D"width:83.25pt;border:solid black 1.0pt;border-left:none;backgr=
ound:#dbe5f1;padding:0cm 1.5pt 0cm 1.5pt;height:14.3pt" valign=3D"top" widt=
h=3D"111">
<p class=3D"MsoNormal" style=3D"text-align:center;text-autospace:none" alig=
n=3D"center">
<b><span style=3D"color:black">Comments<u></u><u></u></span></b></p>
</td>
</tr>
<tr style=3D"height:13.7pt">
<td style=3D"width:63.6pt;border-top:none;border-left:solid black 1.0pt;bor=
der-bottom:none;border-right:solid black 1.0pt;background:#e5dfec;padding:0=
cm 1.5pt 0cm 1.5pt;height:13.7pt" valign=3D"top" width=3D"85">
<p class=3D"MsoNormal" style=3D"text-align:center;text-autospace:none" alig=
n=3D"center">
<b><span style=3D"color:black">On Study <u></u><u></u></span></b></p>
</td>
<td style=3D"width:87.1pt;border-top:none;border-left:none;border-bottom:so=
lid black 1.0pt;border-right:solid black 1.0pt;background:#e5dfec;padding:0=
cm 1.5pt 0cm 1.5pt;height:13.7pt" valign=3D"top" width=3D"116">
<p class=3D"MsoNormal" style=3D"text-align:center;text-autospace:none" alig=
n=3D"center">
<span style=3D"color:black">Day -1<u></u><u></u></span></p>
</td>
<td style=3D"width:151.5pt;border-top:none;border-left:none;border-bottom:s=
olid black 1.0pt;border-right:solid black 1.0pt;background:#e5dfec;padding:=
0cm 1.5pt 0cm 1.5pt;height:13.7pt" valign=3D"top" width=3D"202">
<p class=3D"MsoNormal" style=3D"text-align:center;text-autospace:none" alig=
n=3D"center">
<span style=3D"color:black">Thursday, 14 January 2016<u></u><u></u></span><=
/p>
</td>
<td style=3D"width:63.75pt;border-top:none;border-left:none;border-bottom:s=
olid black 1.0pt;border-right:solid black 1.0pt;background:#e5dfec;padding:=
0cm 1.5pt 0cm 1.5pt;height:13.7pt" valign=3D"top" width=3D"85">
<p class=3D"MsoNormal" style=3D"text-align:center;text-autospace:none" alig=
n=3D"center">
<span style=3D"color:black">14:00<u></u><u></u></span></p>
</td>
<td style=3D"width:83.25pt;border-top:none;border-left:none;border-bottom:s=
olid black 1.0pt;border-right:solid black 1.0pt;background:#e5dfec;padding:=
0cm 1.5pt 0cm 1.5pt;height:13.7pt" valign=3D"top" width=3D"111">
<p class=3D"MsoNormal" style=3D"text-align:center;text-autospace:none" alig=
n=3D"center">
<span style=3D"color:black">Check-in<u></u><u></u></span></p>
</td>
</tr>
<tr style=3D"height:13.7pt">
<td style=3D"width:63.6pt;border:solid black 1.0pt;border-top:none;backgrou=
nd:#e5dfec;padding:0cm 1.5pt 0cm 1.5pt;height:13.7pt" valign=3D"top" width=
=3D"85">
<p class=3D"MsoNormal" style=3D"text-align:center;text-autospace:none" alig=
n=3D"center">
<b><span style=3D"color:black"><u></u>=C2=A0<u></u></span></b></p>
</td>
<td style=3D"width:87.1pt;border-top:none;border-left:none;border-bottom:so=
lid black 1.0pt;border-right:solid black 1.0pt;background:#e5dfec;padding:0=
cm 1.5pt 0cm 1.5pt;height:13.7pt" valign=3D"top" width=3D"116">
<p class=3D"MsoNormal" style=3D"text-align:center;text-autospace:none" alig=
n=3D"center">
<span style=3D"color:black">Day 3<u></u><u></u></span></p>
</td>
<td style=3D"width:151.5pt;border-top:none;border-left:none;border-bottom:s=
olid black 1.0pt;border-right:solid black 1.0pt;background:#e5dfec;padding:=
0cm 1.5pt 0cm 1.5pt;height:13.7pt" valign=3D"top" width=3D"202">
<p class=3D"MsoNormal" style=3D"text-align:center;text-autospace:none" alig=
n=3D"center">
<span style=3D"color:black">Sunday, 17 January 2016<u></u><u></u></span></p=
>
</td>
<td style=3D"width:63.75pt;border-top:none;border-left:none;border-bottom:s=
olid black 1.0pt;border-right:solid black 1.0pt;background:#e5dfec;padding:=
0cm 1.5pt 0cm 1.5pt;height:13.7pt" valign=3D"top" width=3D"85">
<p class=3D"MsoNormal" style=3D"text-align:center;text-autospace:none" alig=
n=3D"center">
<span style=3D"color:black">10.00am<u></u><u></u></span></p>
</td>
<td style=3D"width:83.25pt;border-top:none;border-left:none;border-bottom:s=
olid black 1.0pt;border-right:solid black 1.0pt;background:#e5dfec;padding:=
0cm 1.5pt 0cm 1.5pt;height:13.7pt" valign=3D"top" width=3D"111">
<p class=3D"MsoNormal" style=3D"text-align:center;text-autospace:none" alig=
n=3D"center">
<span style=3D"color:black">check out<u></u><u></u></span></p>
</td>
</tr>
<tr style=3D"height:13.1pt">
<td style=3D"width:63.6pt;border-top:none;border-left:solid black 1.0pt;bor=
der-bottom:none;border-right:solid black 1.0pt;background:#fde9d9;padding:0=
cm 1.5pt 0cm 1.5pt;height:13.1pt" valign=3D"top" width=3D"85">
<p class=3D"MsoNormal" style=3D"text-align:center;text-autospace:none" alig=
n=3D"center">
<b><span style=3D"color:black">On Study <u></u><u></u></span></b></p>
</td>
<td style=3D"width:87.1pt;border-top:none;border-left:none;border-bottom:so=
lid black 1.0pt;border-right:solid black 1.0pt;background:#fde9d9;padding:0=
cm 1.5pt 0cm 1.5pt;height:13.1pt" valign=3D"top" width=3D"116">
<p class=3D"MsoNormal" style=3D"text-align:center;text-autospace:none" alig=
n=3D"center">
<span style=3D"color:black">Day -1<u></u><u></u></span></p>
</td>
<td style=3D"width:151.5pt;border-top:none;border-left:none;border-bottom:s=
olid black 1.0pt;border-right:solid black 1.0pt;background:#fde9d9;padding:=
0cm 1.5pt 0cm 1.5pt;height:13.1pt" valign=3D"top" width=3D"202">
<p class=3D"MsoNormal" style=3D"text-align:center;text-autospace:none" alig=
n=3D"center">
<span style=3D"color:black">Thursday, 21 January 2016<u></u><u></u></span><=
/p>
</td>
<td style=3D"width:63.75pt;border-top:none;border-left:none;border-bottom:s=
olid black 1.0pt;border-right:solid black 1.0pt;background:#fde9d9;padding:=
0cm 1.5pt 0cm 1.5pt;height:13.1pt" valign=3D"top" width=3D"85">
<p class=3D"MsoNormal" style=3D"text-align:center;text-autospace:none" alig=
n=3D"center">
<span style=3D"color:black">14:00<u></u><u></u></span></p>
</td>
<td style=3D"width:83.25pt;border-top:none;border-left:none;border-bottom:s=
olid black 1.0pt;border-right:solid black 1.0pt;background:#fde9d9;padding:=
0cm 1.5pt 0cm 1.5pt;height:13.1pt" valign=3D"top" width=3D"111">
<p class=3D"MsoNormal" style=3D"text-align:center;text-autospace:none" alig=
n=3D"center">
<span style=3D"color:black">Check-in<u></u><u></u></span></p>
</td>
</tr>
<tr style=3D"height:13.7pt">
<td style=3D"width:63.6pt;border:solid black 1.0pt;border-top:none;backgrou=
nd:#fde9d9;padding:0cm 1.5pt 0cm 1.5pt;height:13.7pt" valign=3D"top" width=
=3D"85">
<p class=3D"MsoNormal" style=3D"text-align:right;text-autospace:none" align=
=3D"right"><span style=3D"color:black"><u></u>=C2=A0<u></u></span></p>
</td>
<td style=3D"width:87.1pt;border-top:none;border-left:none;border-bottom:so=
lid black 1.0pt;border-right:solid black 1.0pt;background:#fde9d9;padding:0=
cm 1.5pt 0cm 1.5pt;height:13.7pt" valign=3D"top" width=3D"116">
<p class=3D"MsoNormal" style=3D"text-align:center;text-autospace:none" alig=
n=3D"center">
<span style=3D"color:black">Day 3<u></u><u></u></span></p>
</td>
<td style=3D"width:151.5pt;border-top:none;border-left:none;border-bottom:s=
olid black 1.0pt;border-right:solid black 1.0pt;background:#fde9d9;padding:=
0cm 1.5pt 0cm 1.5pt;height:13.7pt" valign=3D"top" width=3D"202">
<p class=3D"MsoNormal" style=3D"text-align:center;text-autospace:none" alig=
n=3D"center">
<span style=3D"color:black">Sunday, 24 January 2016<u></u><u></u></span></p=
>
</td>
<td style=3D"width:63.75pt;border-top:none;border-left:none;border-bottom:s=
olid black 1.0pt;border-right:solid black 1.0pt;background:#fde9d9;padding:=
0cm 1.5pt 0cm 1.5pt;height:13.7pt" valign=3D"top" width=3D"85">
<p class=3D"MsoNormal" style=3D"text-align:center;text-autospace:none" alig=
n=3D"center">
<span style=3D"color:black">10.00am<u></u><u></u></span></p>
</td>
<td style=3D"width:83.25pt;border-top:none;border-left:none;border-bottom:s=
olid black 1.0pt;border-right:solid black 1.0pt;background:#fde9d9;padding:=
0cm 1.5pt 0cm 1.5pt;height:13.7pt" valign=3D"top" width=3D"111">
<p class=3D"MsoNormal" style=3D"text-align:center;text-autospace:none" alig=
n=3D"center">
<span style=3D"color:black">check out<u></u><u></u></span></p>
</td>
</tr>
<tr style=3D"height:13.7pt">
<td style=3D"width:63.6pt;border:solid black 1.0pt;border-top:none;backgrou=
nd:#b6dde8;padding:0cm 1.5pt 0cm 1.5pt;height:13.7pt" valign=3D"top" width=
=3D"85">
<p class=3D"MsoNormal" style=3D"text-align:center;text-autospace:none" alig=
n=3D"center">
<b><span style=3D"color:black">Final Visit<u></u><u></u></span></b></p>
</td>
<td style=3D"width:87.1pt;border-top:none;border-left:none;border-bottom:so=
lid black 1.0pt;border-right:solid black 1.0pt;background:#b6dde8;padding:0=
cm 1.5pt 0cm 1.5pt;height:13.7pt" valign=3D"top" width=3D"116">
<p class=3D"MsoNormal" style=3D"text-align:center;text-autospace:none" alig=
n=3D"center">
<span style=3D"color:black">Day 7<u></u><u></u></span></p>
</td>
<td style=3D"width:151.5pt;border-top:none;border-left:none;border-bottom:s=
olid black 1.0pt;border-right:solid black 1.0pt;background:#b6dde8;padding:=
0cm 1.5pt 0cm 1.5pt;height:13.7pt" valign=3D"top" width=3D"202">
<p class=3D"MsoNormal" style=3D"text-align:center;text-autospace:none" alig=
n=3D"center">
<span style=3D"color:black">Thursday, 28 January 2016<u></u><u></u></span><=
/p>
</td>
<td style=3D"width:63.75pt;border-top:none;border-left:none;border-bottom:s=
olid black 1.0pt;border-right:solid black 1.0pt;background:#b6dde8;padding:=
0cm 1.5pt 0cm 1.5pt;height:13.7pt" valign=3D"top" width=3D"85">
<p class=3D"MsoNormal" style=3D"text-align:center;text-autospace:none" alig=
n=3D"center">
<span style=3D"color:black">~2hrs<u></u><u></u></span></p>
</td>
<td style=3D"width:83.25pt;border-top:none;border-left:none;border-bottom:s=
olid black 1.0pt;border-right:solid black 1.0pt;background:#b6dde8;padding:=
0cm 1.5pt 0cm 1.5pt;height:13.7pt" valign=3D"top" width=3D"111">
<p class=3D"MsoNormal" style=3D"text-align:center;text-autospace:none" alig=
n=3D"center">
<span style=3D"color:black">Outpatient<u></u><u></u></span></p>
</td>
</tr>
</tbody>
</table>
<p class=3D"MsoNormal"><b><span style=3D"color:#1f497d"><u></u>=C2=A0<u></u=
></span></b></p>
<p class=3D"MsoNormal">To view our Participant Information Brochure please =
<a href=3D"http://clinicalstudies.com.au/wp-content/uploads/2014/02/CCS-Vol=
unteer-Brochure.pdf" target=3D"_blank">
click here</a> and read more about our organisation and about clinical tria=
ls generally.<u></u><u></u></p>
<p class=3D"MsoNormal"><span style=3D"color:red"><u></u>=C2=A0<u></u></span=
></p>
<p class=3D"MsoNormal">Please also visit our website at<span style=3D"color=
:#1f497d">
<a href=3D"http://www.clinicalstudies.com.au" target=3D"_blank">www.clinica=
lstudies.com.au</a> <u></u><u></u></span></p>
<p class=3D"MsoNormal"><b><span style=3D"color:#1f497d"><u></u>=C2=A0<u></u=
></span></b></p>
<p class=3D"MsoNormal"><b><span style=3D"color:#c00000">If you do not wish =
to receive any further emails from us then please reply to this email with =
the word =E2=80=98unsubscribe=E2=80=99 in the subject box.<u></u><u></u></s=
pan></b></p>
<p class=3D"MsoNormal"><u></u>=C2=A0<u></u></p>
<p><span style=3D"font-size:11.0pt;font-family:&quot;Calibri&quot;,&quot;sa=
ns-serif&quot;">Thanking you again for your interest.<span style=3D"color:#=
1f497d">
<u></u><u></u></span></span></p>
<p><span style=3D"font-size:11.0pt;font-family:&quot;Calibri&quot;,&quot;sa=
ns-serif&quot;;color:#1f497d"><u></u>=C2=A0<u></u></span></p>
<p class=3D"MsoNormal"><span style=3D"color:#1f497d"><u></u>=C2=A0<u></u></=
span></p>
<p class=3D"MsoNormal"><span style=3D"color:#1f497d">Warm Regards,<u></u><u=
></u></span></p>
<p class=3D"MsoNormal"><span style=3D"color:#1f497d">Louise<u></u><u></u></=
span></p>
<p class=3D"MsoNormal"><span style=3D"color:#1f497d"><u></u>=C2=A0<u></u></=
span></p>
<p class=3D"MsoNormal"><b><span style=3D"font-size:10.0pt;color:#8db3e2">Lo=
uise Gonzales</span></b><b><span style=3D"font-size:10.0pt;color:#1f497d">|=
</span></b><span style=3D"font-size:10.0pt;color:#1f497d">=C2=A0<b>Senior R=
ecruitment Officer</b>
<b>|</b> </span><b><span style=3D"font-size:10.0pt;color:#00b0f0">Centre fo=
r Clinical Studies</span></b><span style=3D"font-size:10.0pt;color:#99cc00"=
>
</span><b><span style=3D"font-size:10.0pt;color:#1f497d">|</span></b><span =
style=3D"font-size:10.0pt;color:#1f497d">=C2=A0=C2=A0<br>
<b>Office|</b> Level 5 Burnet Institute, AMREP Precinct | 89 Commercial Roa=
d Melbourne=C2=A0Victoria 3004, Australia
<b>|</b><br>
<b>T</b>=C2=A0 61 3 9076 9019 |=C2=A0<b>F</b> 61 3 9076 8940 |<b> E </b></s=
pan><a href=3D"mailto:l.gonzales@nucleusnetwork.com.au" target=3D"_blank"><=
b><span style=3D"font-size:10.0pt;color:#00b0f0">l.gonzales@nucleusnetwork.=
com.au</span></b></a><span style=3D"font-size:10.0pt;color:#1f497d">
 | <b>W</b>=C2=A0 </span><a href=3D"http://www.clinicalstudies.com.au" targ=
et=3D"_blank"><b><span style=3D"font-size:10.0pt;color:#00b0f0">www.clinica=
lstudies.com.au</span></b></a><b><span style=3D"font-size:10.0pt;color:#00b=
0f0">
</span></b><span style=3D"font-size:10.0pt;color:#1f497d">|</span><span sty=
le=3D"color:#1f497d"><u></u><u></u></span></p>
<p class=3D"MsoNormal"><b><span style=3D"font-size:18.0pt;color:#1f497d">18=
00 243 733</span></b><span style=3D"font-size:18.0pt;color:#1f497d">
<u></u><u></u></span></p>
<p class=3D"MsoNormal" style=3D"text-autospace:none"><a href=3D"http://www.=
facebook.com/pages/Centre-for-Clinical-Studies/199371513417842" target=3D"_=
blank"><span style=3D"font-size:10.0pt;font-family:&quot;Arial&quot;,&quot;=
sans-serif&quot;;color:#1f497d;text-decoration:none"><img src=3D"cid:image0=
02.png@01D1495D.7A53BF30" border=3D"0" height=3D"43" width=3D"43"></span></=
a><span style=3D"color:#1f497d">=C2=A0</span><span style=3D"font-size:10.0p=
t;font-family:&quot;Arial&quot;,&quot;sans-serif&quot;;color:#365f91">You
 can now follow us on Facebook</span><span style=3D"color:#1f497d"><u></u><=
u></u></span></p>
<p class=3D"MsoNormal" style=3D"text-autospace:none"><b><span style=3D"font=
-size:8.0pt;font-family:&quot;Arial&quot;,&quot;sans-serif&quot;;color:#00b=
0f0"><u></u>=C2=A0<u></u></span></b></p>
<p class=3D"MsoNormal" style=3D"text-autospace:none"><b><i><span style=3D"f=
ont-size:8.0pt;font-family:&quot;Arial&quot;,&quot;sans-serif&quot;;color:#=
1f497d">Nucleus Network, Australia&#39;s Clinical Research Centre, operates=
 in association with Centre for Clinical Studies,
<u></u><u></u></span></i></b></p>
<p class=3D"MsoNormal" style=3D"text-autospace:none"><b><i><span style=3D"f=
ont-size:8.0pt;font-family:&quot;Arial&quot;,&quot;sans-serif&quot;;color:#=
1f497d">Clinical Trials Consulting and its network partners<u></u><u></u></=
span></i></b></p>
<p class=3D"MsoNormal" style=3D"text-autospace:none"><span style=3D"font-si=
ze:18.0pt;font-family:Webdings;color:green">P</span><span style=3D"font-siz=
e:8.0pt;font-family:&quot;Arial&quot;,&quot;sans-serif&quot;;color:green">=
=C2=A0
<b><i>Please consider the environment before printing this e-mail</i></b></=
span><b><i><span style=3D"font-size:8.0pt;font-family:&quot;Arial&quot;,&qu=
ot;sans-serif&quot;;color:#1f497d"><u></u><u></u></span></i></b></p>
<p class=3D"MsoNormal"><span style=3D"font-size:9.0pt;color:#1f497d"><br>
<br>
</span><span style=3D"color:#1f497d"><u></u><u></u></span></p>
<p class=3D"MsoNormal"><span style=3D"color:#1f497d"><u></u>=C2=A0<u></u></=
span></p>
<p class=3D"MsoNormal"><span style=3D"color:#1f497d"><u></u>=C2=A0<u></u></=
span></p>
<p class=3D"MsoNormal"><u></u>=C2=A0<u></u></p>
</div>
<br clear=3D"all">
______________________________________________________________________<br>
This email has been scanned by the Symantec Email Security.cloud service.<b=
r>
For more information please visit <a href=3D"http://www.symanteccloud.com" =
target=3D"_blank">http://www.symanteccloud.com</a><br>
______________________________________________________________________<br>
</div>


</blockquote></div><br></div>

--94eb2c07d8e417d0f30528b9b820--
--94eb2c07d8e417d0f50528b9b821
Content-Type: image/png; name="image002.png"
Content-Disposition: inline; filename="image002.png"
Content-Transfer-Encoding: base64
Content-ID: <image002.png@01D1495D.7A53BF30>
X-Attachment-Id: a27fa43d06ed9143_0.1
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--94eb2c07d8e417d0f50528b9b821--